MedPath

THE COOPER HEALTH SYSTEM

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

60

Active:3
Completed:22

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:5
Phase 2:6
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (50 trials with phase data)• Click on a phase to view related trials

Not Applicable
23 (46.0%)
Phase 4
11 (22.0%)
Phase 2
6 (12.0%)
Phase 1
5 (10.0%)
Phase 3
3 (6.0%)
Early Phase 1
2 (4.0%)

Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization

Not Applicable
Not yet recruiting
Conditions
ICH - Intracerebral Hemorrhage
TBI Traumatic Brain Injury
IVH- Intraventricular Hemorrhage
First Posted Date
2025-06-27
Last Posted Date
2025-06-27
Lead Sponsor
The Cooper Health System
Target Recruit Count
50
Registration Number
NCT07042048
Locations
🇺🇸

Cooper University Health, Camden, New Jersey, United States

Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy

Not Applicable
Recruiting
Conditions
Lung Cancer
Pneumonitis
Radiation-Induced Lung Injury
Immunotherapy-Induced Pneumonitis
Non-Small-Cell Lung Cancer (NSCLC)
First Posted Date
2024-11-14
Last Posted Date
2024-12-10
Lead Sponsor
The Cooper Health System
Target Recruit Count
100
Registration Number
NCT06688422
Locations
🇺🇸

MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States

Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection

Phase 1
Recruiting
Conditions
Chronic Subdural Hematoma
Interventions
First Posted Date
2024-07-19
Last Posted Date
2025-07-01
Lead Sponsor
The Cooper Health System
Target Recruit Count
140
Registration Number
NCT06510582
Locations
🇺🇸

Cooper University Health Care, Camden, New Jersey, United States

Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1

Phase 1
Completed
Conditions
Refractory Migraine
Interventions
First Posted Date
2024-06-17
Last Posted Date
2025-06-10
Lead Sponsor
The Cooper Health System
Target Recruit Count
10
Registration Number
NCT06462781
Locations
🇺🇸

Cooper University Health Care, Camden, New Jersey, United States

Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

Conditions
Cryptogenic Stroke
First Posted Date
2024-05-03
Last Posted Date
2025-01-23
Lead Sponsor
The Cooper Health System
Target Recruit Count
2000
Registration Number
NCT06398366
Locations
🇺🇸

Cooper Health System, Camden, New Jersey, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath